Which stock wins in a matchup between these two fast-growing Canadian marijuana producers?
Three very different stocks with one thing in common: They could all be winners for long-term investors.
The small biotech stock soared thanks to a big deal with a big pharma company.
A mistake on a figure in Canopy Growth's third-quarter earnings release raises some concerns.
The healthcare technology company announced a nice Q4 revenue jump, but investors were still disappointed.
The drugmaker posted a loss in the fourth quarter as sales declined for products facing generic rivals, but its organic revenue grew.
The acquisition of Aetna wasn't enough to offset continued problems for the pharmacy services giant's struggling long-term care business.
Tilray's acquisition of the world's largest hemp food company could give the Canadian marijuana producer an edge over its top rivals.
Investors were disappointed by the company's lackluster Q4 earnings update.
Investors are enthusiastic after the biotech reported positive late-stage results for its liver-disease drug.
And what to look forward to based on the big Canadian marijuana growers' latest quarterly results.
This marijuana stock is simply the best in the business.
Innovative insulin pumps and promising drugs make these three companies worthy of investors' attention.
Two of the biggest Canadian marijuana companies provided quarterly updates last week. Their results could be good news for other marijuana stocks, too.
Which stock wins in a battle between a top Canadian marijuana grower and a big alcoholic beverage company with a big bet on marijuana?
Great dividends. Solid business models. And Warren Buffett likes them. What more could you ask for?
There's good news and there's bad news for this big biotech.
Sizzling growth. Impressive prospects. But are they enough for Exact Sciences to make you a millionaire in the future?
This marijuana stock has a lot of potential. But that potential has yet to be realized.
These drugmakers' profit margins are sky-high. But does that necessarily mean they're great stocks to buy?